The path from target to Investigational New Drug/Molecular Diagnostics is long and complex....
Finding functional, target-binding leads isn’t enough!!!!
Nanobodies are synthetic single domain, engineered target-binding fragments that has the potential to replace current animal-harvested antibodies for
molecular diagnostics applications in human healthcare, animal breeding, agriculture and food safety.
bioLOCKEY has taken the science of Nanobody discovery to another level by using bio-computational technique to design and optimise the binding between Nanobody and target molecules in a 3D virtual environment – at least 20X faster and cheaper than conventional lab-based methods.
Find optimal clinical candidates with speed and precision.
Integrated high-throughput nanobody assessment and computational methods increase the likelihood of finding optimal development candidates sooner.
Comments